ArticleOncology and therapy2021

A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy.

Chin-Chou Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.